Jeffrey Robert Ajer, EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 14,331 shares at $81.78 ($1.2M) on 2022-03-23, disclosed to the SEC on 2022-03-24.
Seasonal sale ($1.2M) by EVP, Chief Commercial Officer — this insider has traded BMRN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.00 | 2,073 | $168K | 14.3% |
| 2 | $81.78 | 6,129 | $501K | 42.8% |
| 3 | $81.78 | 6,129 | $501K | 42.8% |
| Total | $81.67 avg | 14,331 | $1.2M | 100% |
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |